| Mr Robert P Hennon, MD | |
|
520 Upper Chesapeake Dr Ste 412, Bel Air, MD 21014-4381 | |
| (443) 643-4400 | |
| (443) 643-4404 |
| Full Name | Mr Robert P Hennon |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 33 Years |
| Location | 520 Upper Chesapeake Dr Ste 412, Bel Air, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629009485 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | D0086337 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Umd Upper Chesapeake Medical Center | Bel air, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upper Chesapeake Surgical Associates, Llc | 8729181805 | 21 |
News Archive
The Texas Center for Quality & Patient Safety announced today that Blue Cross and Blue Shield of Texas is continuing its support for the TCQPS with a $150,000 donation to study and improve patient safety, including reduction of hospital readmissions and hospital-acquired infections.
Services for veterans have improved recently, but many veterans say more improvements still need to be made.
A drug policy researcher is proposing a suite of changes to overhaul the Multi-Criteria Drug Harm Scale, which informs drug policies across Europe.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.
› Verified 2 days ago
| Entity Name | Upper Chesapeake Surgical Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629175997 PECOS PAC ID: 8729181805 Enrollment ID: O20070309000291 |
News Archive
The Texas Center for Quality & Patient Safety announced today that Blue Cross and Blue Shield of Texas is continuing its support for the TCQPS with a $150,000 donation to study and improve patient safety, including reduction of hospital readmissions and hospital-acquired infections.
Services for veterans have improved recently, but many veterans say more improvements still need to be made.
A drug policy researcher is proposing a suite of changes to overhaul the Multi-Criteria Drug Harm Scale, which informs drug policies across Europe.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Robert P Hennon, MD 520 Upper Chesapeake Dr Ste 412, Bel Air, MD 21014-4381 Ph: (443) 643-4400 | Mr Robert P Hennon, MD 520 Upper Chesapeake Dr Ste 412, Bel Air, MD 21014-4381 Ph: (443) 643-4400 |
News Archive
The Texas Center for Quality & Patient Safety announced today that Blue Cross and Blue Shield of Texas is continuing its support for the TCQPS with a $150,000 donation to study and improve patient safety, including reduction of hospital readmissions and hospital-acquired infections.
Services for veterans have improved recently, but many veterans say more improvements still need to be made.
A drug policy researcher is proposing a suite of changes to overhaul the Multi-Criteria Drug Harm Scale, which informs drug policies across Europe.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.
› Verified 2 days ago
Dr. David Marshall Lanphear, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2515 Fairway Dr., Bel Air, MD 21015 Phone: 410-836-5016 | |
Dr. Peter J Mackrell, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Upper Chesapeake Dr, Suite 306, Bel Air, MD 21014 Phone: 410-879-2006 Fax: 410-879-0248 | |
Philip Andrew Rivera, MD Surgery Medicare: Medicare Enrolled Practice Location: 520 Upper Chesapeake Dr Ste 306, Bel Air, MD 21014 Phone: 410-879-2006 | |
Andre Biuckians, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Upper Chesapeake Dr, Suite 306, Bel Air, MD 21014 Phone: 617-512-7277 | |
Dr. Richard A Bafford, MD, MSPH Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Upper Chesapeake Dr, Suite 306, Bel Air, MD 21014 Phone: 410-879-2006 | |
Dr. Mathew A. Thomas, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2012 S Tollgate Rd, Suite 100, Bel Air, MD 21015 Phone: 410-569-5155 Fax: 410-569-5166 | |
Dr. Roger E Schneider, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Upper Chesapeake Dr, Suite 306, Bel Air, MD 21014 Phone: 410-879-2006 Fax: 410-879-0248 |